CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Guangzhou Baiyunshan Pharmaceutical Co. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Guangzhou Baiyunshan Pharmaceutical Co.
88 Yuxiang Rd, Tonghe,, Baiyun
Phone: +86 2087062599p:+86 2087062599 Guangzhou, GNG  510515  China Fax: +86 2087705599f:+86 2087705599
This company was Merged or Acquired on 4/26/2013.
This is a Subsidiary, click here for the Parent Company
Business Summary
Guangzhou Baiyunshan Pharmaceutical Co., Ltd. is principally engaged in the pharmaceutical industry. The Company’s main businesses are production of chemical raw medicines and pharmaceutical preparations, as well as the processing of traditional Chinese medical materials and Chinese traditional patent medicines. The Company’s products include medium and long chain fat emulsion injection, amoxicillin capsules, cephathiamidine for injection, compound dexamethasone acetate cream, cefalexin capsules, cefixime capcules, norfloxacin capsules, cefradine capsules, cefaclor tablets, ceftraixone sodium for injection, among others, as well as other Chinese medicines, compound of Chinese and Western medicine, bulk pharmaceuticals and others. The Company mainly operates its businesses in domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/201512/31/2015Yes----

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries
2836 Biological products, except diagnostic substances
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board ChuyuanLi 53 6/30/2011 6/30/2011
Chief Financial Officer ZhilingHuang 54 5/1/2005 5/1/2005
General Manager, Director WenchuWang 46 6/23/2010 6/23/2009
7 additional Officers and Directors records available in full report.

General Information
Number of Employees: 5,390 (As of 12/31/2012)
Outstanding Shares: 1,291,079,250 (As of 12/31/2015)
Shareholders: 59,140
Stock Exchange: SHE
Fax Number: +86 2087705599


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023